Jo-Ann I Sheppard

Jo-Ann I Sheppard

UNVERIFIED PROFILE

Are you Jo-Ann I Sheppard?   Register this Author

Register author
Jo-Ann I Sheppard

Jo-Ann I Sheppard

Publications by authors named "Jo-Ann I Sheppard"

Are you Jo-Ann I Sheppard?   Register this Author

26Publications

220Reads

-Profile Views

High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.

J Thromb Haemost 2019 May 14;17(5):841-844. Epub 2019 Mar 14.

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jth.14411DOI Listing
May 2019

Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.

Int J Lab Hematol 2019 May 3. Epub 2019 May 3.

Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/ijlh.13031
Publisher Site
http://dx.doi.org/10.1111/ijlh.13031DOI Listing
May 2019

Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia.

Thromb Haemost 2019 Apr 20. Epub 2019 Apr 20.

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1683913DOI Listing
April 2019

Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.

Transfusion 2019 Mar 23. Epub 2019 Mar 23.

Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15263DOI Listing
March 2019

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT.

Blood 2018 Sep 31;132(12):1345-1349. Epub 2018 Jul 31.

Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-847483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202723PMC
September 2018

Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.

Chest 2018 Jun 8;153(6):1396-1404. Epub 2018 Jan 8.

Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; McMaster Centre for Transfusion Research, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2018.01.001DOI Listing
June 2018

Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.

Thromb Haemost 2017 10 24;117(10):1868-1874. Epub 2017 Aug 24.

Andrew Shih, MD, FRCPC, DRCPSC, BSc, Vancouver General Hospital, Department of Pathology, JPP1, room 1553, 855 West 12th Avenue, Vancouver, B. C. V5Z 1M9, Canada, Tel.: +1 604 875 4111 Ext. 61109, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH17-03-0212DOI Listing
October 2017

Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.

Exp Hematol Oncol 2017 14;6:21. Epub 2017 Jul 14.

Department of Hematology and Oncology, William Beaumont Hospital, Oakland University William Beaumont School of Medicine, 3577 W. 13 Mile Rd., Suite 202a, Royal Oak, MI USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40164-017-0080-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513338PMC
July 2017

Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL HIT-Ab] for the diagnosis of immune heparin-induced thrombocytopenia.

Thromb Res 2017 May 11;153:108-117. Epub 2017 Mar 11.

Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster Centre for Transfusion Research, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00493848173023
Publisher Site
http://dx.doi.org/10.1016/j.thromres.2017.03.010DOI Listing
May 2017

Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite "Therapeutic" Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding.

J Cardiothorac Vasc Anesth 2015 Oct 29;29(5):1319-21. Epub 2014 Aug 29.

Cardiovascular Research and Quality Programs, Ernst Cardiovascular Center, Beaumont Hospital, Royal Oak, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jvca.2014.04.029DOI Listing
October 2015

The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study.

Chest 2015 Jul;148(1):55-61

Pulmonary and Critical Care Section, MedStar Washington Hospital Center, and Georgetown University Medical Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.14-1417DOI Listing
July 2015

Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin.

Blood 2014 Apr 10;123(16):2485-93. Epub 2014 Feb 10.

Department of Pathology and Molecular Medicine and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-10-533083DOI Listing
April 2014

Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.

Transfusion 2009 Sep 20;49(9):1812-8. Epub 2009 May 20.

Institut für Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universität, Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2009.02205.xDOI Listing
September 2009

The temporal profile of the anti-PF4/heparin immune response.

Blood 2009 May 23;113(20):4970-6. Epub 2008 Dec 23.

Institut für Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universität Greifswald, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-08-173062DOI Listing
May 2009

Studies of the immune response in heparin-induced thrombocytopenia.

Blood 2009 May 14;113(20):4963-9. Epub 2009 Jan 14.

Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-10-186064DOI Listing
May 2009

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia.

Blood 2006 Nov 20;108(9):2937-41. Epub 2006 Jul 20.

Department of Pathology, Hamilton Regional Laboratory Medicine Program, Rm 1-180A, Hamilton Health Sciences, Hamilton General Site, McMaster University, 237 Barton St E, Hamilton, ON L8L2X2 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-11-012450DOI Listing
November 2006

Testing for heparin-induced thrombocytopenia antibodies.

Transfus Med Rev 2006 Oct;20(4):259-72

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmrv.2006.05.001DOI Listing
October 2006

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

J Lab Clin Med 2005 Dec;146(6):341-6

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S002221430500282
Publisher Site
http://dx.doi.org/10.1016/j.lab.2005.08.003DOI Listing
December 2005

Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.

Thromb Haemost 2005 Nov;94(5):958-64

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH05-03-0154DOI Listing
November 2005